Gabather AB (publ) (STO:GABA)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.0454
+0.0010 (2.25%)
Mar 9, 2026, 5:29 PM CET
-30.15%
Market Cap 21.83M
Revenue (ttm) n/a
Net Income (ttm) -4.65M
Shares Out 491.63M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 13,728,794
Average Volume 2,340,729
Open 0.0460
Previous Close 0.0444
Day's Range 0.0350 - 0.0576
52-Week Range 0.0230 - 0.1300
Beta -0.32
RSI 69.35
Earnings Date May 29, 2026

About Gabather AB

Gabather AB (publ), a pharmaceutical company, develops drug candidates for the treatment of central nervous system diseases. The company offers drugs primarily in the areas of anti-psychotics, anti-depressants and anxiolytics, and analgesics, as well as cognition-enhancing treatments, including Alzheimer’s disease. It focuses on developing GT-002, a pro-cognitive drug candidate for the treatment of Alzheimer’s disease, schizophrenia, and major depressive disorders. The company was incorporated in 2014 and is based in Södertälje, Sweden. [Read more]

Sector Healthcare
Founded 2014
Employees 3
Stock Exchange Nasdaq Stockholm
Ticker Symbol GABA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.